MoneyWorks4Me

Venmax Drugs & Pharmaceuticals informs about statement of investor complaints

21 Jul 2017 Evaluate

Venmax Drugs & Pharmaceuticals has informed about the Statement of Investor Complaints for the Quarter ended 30th June 2017 under regulation 13 (3) of the SEBI (LODR) Regulation 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..